WO1996000296A1 - Procede de production de d-amino acide au moyen d'une preparation a base d'une enzyme composite immobilisee - Google Patents
Procede de production de d-amino acide au moyen d'une preparation a base d'une enzyme composite immobilisee Download PDFInfo
- Publication number
- WO1996000296A1 WO1996000296A1 PCT/JP1995/001257 JP9501257W WO9600296A1 WO 1996000296 A1 WO1996000296 A1 WO 1996000296A1 JP 9501257 W JP9501257 W JP 9501257W WO 9600296 A1 WO9600296 A1 WO 9600296A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coli
- ferm
- enzyme
- producing
- amino acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/009—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
Definitions
- the present invention relates to a composite immobilized enzyme preparation and a method for producing D-amino acid using the same.
- the composite immobilized enzyme preparation of the present invention is particularly useful for producing D-amino acids which are intermediate materials for antibiotics such as D- (p-hydroxyphenyl) glycine used for producing the antibiotic amoxicillin.
- Optically active D-amino acids which are important compounds as pharmaceutical intermediates, are not capable of converting 5-substituted hydantoins to the corresponding D-N-potassium monoamino acid by the action of the enzyme hydantoinase (hereinafter abbreviated as Hase).
- Hase the enzyme hydantoinase
- the present invention provides a method for simultaneously immobilizing two enzymes, hydantoinase and decarbamylase, on the same immobilized resin carrier in the presence of two enzymes (hereinafter, referred to as a complex enzyme), and efficiently using this immobilized enzyme resin. It relates to the technology for producing one amino acid.
- the hydantoinase reaction is generally optimal ⁇ ka ⁇ ⁇ 8-9, with increasing solubility of the substrate as ⁇ increases, and hydantoin. It is desirable that the ⁇ during the reaction be in the range of 7 to 10 and more preferably in the alkaline range, because the racemization reaction of the ring is promoted in the alkaline state.
- the optimal ⁇ is generally ⁇ 6.5 to 9.0.However, as ⁇ increases, the inhibition of the reaction of the product by ammonia increases rapidly. It is preferable to carry out near neutrality.
- the present inventors have conducted intensive studies on preparing a composite immobilized enzyme preparation in which both enzymes are simultaneously immobilized on the same immobilized carrier. Both these enzymes When immobilization is carried out simultaneously, two enzymatic reactions occur consecutively in the space inside the small resin, and the substrate for decarbamylase, D-N-force rubamyl-amino acid, diffuses from the immobilized Hase and is immobilized. In addition, the need to transfer to activated DCase is eliminated, and the pH fluctuation in the micro space can be reduced, increasing the reactivity of each enzyme, reducing product inhibition by ammonia, and reducing the possibility of repeated reactions. It was thought that the stability of the enzyme was also improved.
- the present invention relates to a hydantoinase (hereinafter, abbreviated as Hase) having an optimum pH in an alkaline region and a D-N-caprolactam having an optimum pH near neutrality on an immobilization carrier comprising an anion exchange resin. It is characterized in that a complex immobilized enzyme, which is simultaneously immobilized in the presence of amino acid amide hydrolase (hereinafter abbreviated as D Case) (hereafter referred to as a complex enzyme), is used at a pH around neutrality.
- D Case amino acid amide hydrolase
- the present invention provides a method for efficiently producing the corresponding D-amino acid from a DL-5-substituted hydantoin in a one-step reaction.
- hydantoinase used in the present invention those derived from animals, plants and microorganisms can be used, but microorganisms are suitable for industrial production.
- microorganisms include, for example, those disclosed in Japanese Patent Publication No. Sho 62-30758.
- Streptomyces S treptomyces
- Akuchinopuranesu genus a ctinoplanes
- Asuperugirusu genus as belonging to fungi (Asper gillus)
- Nono 0 Eshiromisesu genus Paecilomyces
- Bae Nishiriumu genus P enic illium
- Candida the genus Pichia
- Rhodotorula the genus Torulopsis and so on.
- strains having relatively high hydantoinase activity and excellent practicality include Aerobacter cloacae I AM 1221, Agrobacterium rhizogenes. rhizogenes) I FO 13259, Brevibacterium incertum IF 0 12145, Corynebacterium seperonicum.
- Sedonicum (C orynebacterium sepedonicum) F 3306, Microbacterium flavum (Microbacterium flavum A) TCC 10340, Micrococcus roseus (Micrococcus roseus) IF 0 3764, Pseudomonas striata (IF 0 12996), Mycobacterium (Mycobacterium smegmatis) ATCC 607, Nocardia cor 3338 I The Streptomyces' Flaveolas (Streptomyces flaveolus) IFO 3241, Bee Vinegar species (Bacillus sp.) KNK 108 (FERM P-6056), Bacillus sp. KNK 245 (FERM BP-4863), etc.
- Microorganisms given hydantoinase-producing ability by genetic recombination For example, E. coli HB10 lpTH104 (FERM BP-4864), or an enzyme produced by an enhanced artificial microorganism, or JP-A-53-136583, which has equivalent activity
- E. coli HB10 lpTH104 (FERM BP-4864)
- an enzyme produced by an enhanced artificial microorganism or JP-A-53-136583, which has equivalent activity
- JP-A-53-136583 JP-A-53-136583
- the origin of the decarbamylase used in the present invention is not particularly limited, such as animals, plants, and microorganisms, but microorganisms are suitable for industrial production.
- microorganisms include Agrobacterium, Pseudomonas, Arthrobacter, Alkaligenes, and A. disclosed in JP-B-57-18793, JP-B-63-20520, and JP-B-1-48758.
- Natural microorganisms such as the genus Chromobacter, the genus Moraxella, the genus Paracoccus, the genus Aerobacter, the genus Aeromonas, the genus Brevibacterium, the genus Bacillus, the genus Flavobacterium, and the genus Serratia, and gene sets as described in WO 91/01696
- An artificial microorganism that has been given or enhanced the ability to produce a weakened rubamil enzyme by replacement is mentioned.
- Representative examples of these microorganisms include Aggropacterium 'species (Agrobacterium sp.) KNK 712 (FERM BP-1900) and Pseudomonas sp.
- J Ml 09 pAD 406 (FERM BP-3914), E. coli J Ml 09 pAD 416 (FERM BP-3915, CCTCC NO: M 93040), E. coli JM109 pAD428, E-Joli JM1 09 pAD429 (FERM BP) -4035), — J JM109 pAD431, — '109 JM109 pAD434, ⁇ J JM1 09 pAD435,' ⁇ ⁇ J JM109 pA D 439, ⁇ J JMl 09 pAD441, ⁇ ' ⁇ ⁇ Koli JM109 pAD 445. E. coli JM109 pAD447, E.
- the enzymes used in the present invention can be produced simultaneously using microorganisms that can produce both enzymes simultaneously, or they can be produced separately or simultaneously using microorganisms that produce each enzyme alone.
- Bacteria capable of producing both enzymes include strains isolated from the natural world, for example, JP-B-63-2052
- both enzyme genes can be isolated from the same or different microorganisms and inserted into the same vector so that both genes can be expressed, or different vectors with different replication modes, such as pUC19 and pACYC184 And transforming it into a host into which E. coli or the like can be introduced so that one type of recombinant microorganism can produce and use both enzymes.
- the cultivation can be performed by aerobic cultivation, for example, by shaking cultivation using a flask or the like, or by aeration and stirring cultivation using a stirring type culturing tank or the like.
- a medium to be used in this case generally used natural nutrients, for example, a nutrient medium containing a meat extract or polypeptone can be used, but hydantoinase alone or simultaneously can be used.
- good results can be obtained by adding manganese ions, for example, as manganese chloride in an amount of about 1 to 10 Omg / liter, preferably about 2 Omg / liter.
- the enzyme to be used may be present as a purified enzyme, a partially purified enzyme, or a crude enzyme in the immobilized enzyme preparation in some cases as it is in the form of cells, and it may be in a state where each enzyme activity can be exhibited. For example, it does not matter whether it exists or coexists.
- antioxidants include dithiothreitol and 2-mercapto. Tetanol, L-cysteine hydrochloride, cysteamine hydrochloride, dithioerythritol, a mixture of dithiothreitol and dithioerythritol, reduced glutathione and the like can be used.
- the immobilization support to be used depends on the mode of immobilization of the enzyme to be used.However, when a crude enzyme solution such as a cell-free extract or a partially purified enzyme solution subjected to ammonium sulfate fractionation is used for immobilization, Polymer supports having ion exchange groups or covalent bonding groups can be used.
- polymer support having an ion-exchange group examples include an anion-exchange resin, for example, Duolite (registered trademark) A having an exchange group of a primary, secondary, tertiary or quaternary amine, or Amberlite IRA ( (Registered trademark) series or polystyrene resin having a functional group of a diethanol type, such as Diaion EX. Can be used.
- anion-exchange resin for example, Duolite (registered trademark) A having an exchange group of a primary, secondary, tertiary or quaternary amine, or Amberlite IRA (Registered trademark) series or polystyrene resin having a functional group of a diethanol type, such as Diaion EX. Can be used.
- Examples of the polymer having a covalent bonding group include a substituted polymethacrylic acid polymer having an aldehyde as a bonding group, and a high-density alumina coated with a polyethyleneiminoglutaraldehyde conjugate.
- polymers such as polyacrylamide, polyurethane or calcium alginate, and porous materials such as pumice and alumina can be used.
- the composite immobilized enzyme preparation of the present invention is produced as follows.
- a complex crude enzyme solution in which the enzyme titer of each of Hase and D Case is appropriately adjusted, is brought into contact with the support, and each enzyme is adsorbed and treated with a crosslinking agent to stabilize.
- the cells are cultured to produce each enzyme.
- the cells can be collected and a cell-free extract can be prepared by sonication, mechanical crushing (such as a homogenizer), or enzyme treatment.
- Both enzymes can be prepared by, for example, mixing and culturing the respective producing bacteria, and simultaneously disrupting the cells to prepare a cell-free extract in which the two enzymes are mixed.
- the productivity varies greatly depending on the type of bacteria and the cultivation method.
- hydantoinase is usually 0.1 to 10 units / ml (here One unit of the enzyme converts the substrate 5- (p-hydroxyphenyl) hydantoin to D-N-force rubamyl-p-hydroxyfujylglycine in 1 minute at 40 ° C and pH 8.7.
- the amount of enzyme needed to produce the recombinant artificial microorganism is about 5 to 150 units Zml, and the amount of decarbamylase is about 0.01 to 2 units for normal bacteria. Unit: 40 ° C, pH 7.0 Is the amount of enzyme required to convert the substrate D—N—force rubamil-p-hydroxyphenylglycine to D—p—hydroxyphenylglycine in 1 minute.) 1 to 20 units About Zml. Hase and DC in complex crude yeast solution
- the ratio of enzyme titer of ase is adjusted so that the reaction to produce D-amino acid from 5-substituted hydantoin proceeds most effectively.
- this reaction since this reaction is performed near neutral pH close to the optimal pH of the D Case, the activity of both enzymes is regulated due to factors such as the condition that the activity of Hase is not maximized. Therefore, it is desirable that the same enzyme activity be exhibited at the reaction pH.
- the immobilization reaction is performed using an enzyme solution containing approximately 5 times the amount of hydantoinase in approximately the same amount of protein and activity ratio to achieve the desired composite immobilization. Enzyme preparation can be prepared.
- the ratio of the enzyme titer in the complex crude enzyme solution be in the range of Hase: D Case of 1 to 10: 1. Therefore, the enzyme titer of the complex crude enzyme solution is adjusted in this way after disruption of the cells and before adsorption.
- the concentration of the amount of decarbamylase in the complex crude enzyme solution is preferably set to 10 to 300 units / ml.
- the titer of the enzyme to be adsorbed is about 20 to 90% of the added enzyme, and there is no great difference between both enzymes.
- the support used is such that the exchange group is activated with a saline solution or the like and then equilibrated in a buffer or the like.
- the ratio of the composite crude enzyme solution to the support is preferably such that the total protein content of the crude enzyme solution is the same as the maximum amount of adsorption on the support. If necessary, add an antioxidant of 1 to 1 ⁇ ⁇ and 0.5 to 2 OmM of manganese ion, and stir at 4 to 30 ° C, preferably 15 ° C to adsorb the enzyme.
- the desired amount After the desired amount has been reached (usually for 8 to 48 hours, preferably in an atmosphere of an inert gas such as nitrogen), it is collected by filtration, washed, treated with a cross-linking agent, insolubilized and stabilized .
- a cross-linking agent for example, a known one such as 1% or less (preferably 0.1 to 0.2%) of glutaraldehyde can be used.
- Wash the cross-linked complex immobilized enzyme preparation with distilled water or a buffer solution (containing 0.1 to 20 mM of the above-described antioxidant, usually containing 1 to 5 mM). (About 4 DC ) and store in a closed container in a wet state.
- the enzymatic activity of the complex immobilized enzyme preparation thus obtained is generally about 1 to 10 times that of decarbamylase, depending on the conditions of the support and of hydantoinase, depending on the conditions at the time of adsorption. There is activity per support.
- the complex-immobilized enzyme preparation is allowed to act on the reaction substrate, 5-substituted hydantoin, if necessary, in the presence of an antioxidant and / or manganese ion.
- the reaction is preferably performed in the presence of 0.1 to 2 O mM of an antioxidant and manganese ion.
- R represents a phenyl group, a phenyl group substituted with a hydroxyl group, an alkyl group, a substituted alkyl group, an aralkyl group or a phenyl group).
- the concentration of the reaction substrate, 5-substituted hydantoin, is 0.1 to 30 wZv%, preferably 1 to 5 wZv%.
- the amount of the complex immobilized enzyme preparation to be used is preferably about 10 to 20 units / g substrate based on decarbamylase activity per substrate.
- the reaction temperature varies depending on the enzyme, but generally 30 ° C. to 60 ° C., and particularly higher temperature can be used for a thermostable enzyme.
- the reaction pH is appropriately selected from the range of 6.5 to 8.0. In this pH range, DCase is almost near the optimal pH, but Hase is far from the optimal pH, and its activity is reduced by a factor. Racemization of DL-5-substituted hydantoins is also slowing. However, since the production of D- ⁇ -amino acids is ultimately governed by D Case, which is the enzyme in the last step, the amount of enzyme and reaction conditions (that is, the optimal conditions for D Case) are set based on this. It is preferable to combine the Hase activity with the Hase activity. Depending on the reaction conditions, the ratio of the adsorbed enzyme is generally adjusted so that the same activity can be expressed.
- the same level of activity means that the activity of hydantoinase (expressed in units (PH7.5)) measured at a reaction pH, for example, pH 7.5, and the above-mentioned decarbamylase activity are approximately 0.5 to 1.5: 1. Is the state that is. The reaction is performed while controlling at the pH range selected in this way, usually pH 7.5. These tasks overcome the disadvantageous conditions of Hase, and shift the equilibrium reaction toward the direction of DN-force rubamilaminoic acid, allowing the reaction to proceed more efficiently than expected, and the substrate, 5-substituted hydantoin. The conversion yield can be improved.
- the reaction is When the reaction is performed in the near-alkaline region, it is good until the production of DN-galvanamic acid, but the activity of decarbamylase is reduced to 1Z2 or less, and furthermore, the amount of ammonia generated by the reaction is large. It has been found that the overall reaction efficiency is reduced and the stability of decarbamylase itself is also reduced due to reaction inhibition. For these reasons, the reaction using the composite immobilized enzyme preparation is not suitable for the decarbamylase reaction under the optimal reaction conditions and near the reaction substrate concentration. The use of the combined immobilized enzyme preparation can be carried out efficiently. In addition, conditions such as high productivity of Has e and irreversible reaction of D Case make it advantageous to regulate the overall enzyme activity of the complex immobilized enzyme preparation.
- the reaction is carried out by a column method or suspension in a reactor. In the latter case, a batch reaction is usually carried out, and the reaction time is usually about 6 to 48 hours per batch.
- the composite immobilized enzyme preparation of the present invention was used, it was possible to efficiently produce the corresponding D-amino acid with high optical purity and high yield from 5-substituted hydantoin in a one-step reaction.
- the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.
- Bacillus sp. KNK108 (FERM P-6056) was added to a 25 mlml seed mother medium (1.0% meat extract, 1.0% polypeptone, 0.5% yeast extract (pH 7.0) to prepare the hydantoinase enzyme solution. 0)) and cultured at 33 ° C for about 25 hours. This is inoculated into 2.5 liters of main culture medium (1.0% meat extract, 1.0% polypeptone, 0.5% yeast extract, 0.1% peracil, 2 Opm MnCl 2 (H7.5)), and cultured at 33 ° C for about 16 hours. did.
- the cells cells were collected by centrifugation, 20 mM of 50ml MnS0 4 After suspending in an aqueous solution and adjusting the pH to 8.5, the cells were disrupted by ultrasonication, and the residue was removed by centrifugation to obtain a crude hydantoinase enzyme solution (107 units / ml).
- E. coli HB101P T4553 (FERM BP-4368) to 20 ml of 2YT medium (1.6% pak tryptone, 1.0% bacto yeast extract, 0.5% Na CD in 50%).
- 2YT medium (1.6% pak tryptone, 1.0% bacto yeast extract, 0.5% Na CD in 50%.
- Preculture was performed at 37 ° C for about 16 hours in a medium supplemented with zg / ml ampicillin, and this was inoculated with 1% in 1.4 liters of 2YT medium, and cultured at 37 ° C for about 28 hours.
- the cells are collected by centrifugation, suspended in 140 ml of a 5 mM dithiothreitol solution, adjusted to pH 7.0, disrupted by ultrasonication, and the residue is removed by centrifugation. (36 units / ml).
- Example 2 Using the crude enzyme solution obtained in Example 1, the enzyme was immobilized.
- Duolite A-568 (Rohm & Haas) was first used as a carrier for immobilization, and the pH was adjusted to 7.5 in ion-exchanged water after washing with 1M NaCl and ion-exchanged water.
- To 8.4 g of this resin were added 20 ml and 11.5 ml of a crude enzyme solution of hydantoinase and decarbamylase adjusted to pH 7.5, respectively, and the mixture was stirred at 15 ° C. for about 20 hours under a nitrogen atmosphere. After the resin washed twice with 0.5mM MnS_ ⁇ 4 solution, and suspended in 5 volumes of deionized water, pH 7.
- Example 2 Using the composite immobilized enzyme preparation obtained in Example 2 and the immobilized enzyme of each enzyme alone, a reaction was performed to generate the corresponding D-a-mamino acid from the 5-substituted hydantoin in a one-step reaction. .
- Bacillus ⁇ species having the hydantoinase gene of 245 (FERM BP-4863) was used.
- the HB101pTH104 (FERM BP-4864) was added to 20 ml of 2YT medium at 37 ° C. Precultured for 16 hours. In 2 YT medium this 1.2 rate Torr, 50 ⁇ gZml ampicillin, and were 26 hours of culture at 40 Oppm of MnCl 2. 4H 2 0 in a medium supplemented with 37 ° C.
- the cells were centrifuged and harvested, suspended in 11111 ⁇ MnS_ ⁇ 4 aqueous solution 801 111, was adjusted to 8.5 pH with aqueous ammonia, and disrupted by ultrasonic to remove the residue by centrifugation . After adjusting the supernatant to pH 8.5, it is heat-treated at 60 ° C for 20 minutes to remove the denatured protein by centrifugation.
- Example 2 Using this crude enzyme solution and the crude decarbamylase enzyme solution (240 units / ml) prepared in the same manner as in Example 1, a composite immobilized enzyme preparation was prepared by the method shown in Example 2. 30 ml of crude enzyme solution of decarbamylase and Hydantoina 13 ml of the crude enzyme solution was immobilized on 29 g of the resin by the method shown in Example 2 (45 units of decarbamylase, 119 units of hydantoinase, 44 units (pH 7.5) per gram of resin).
- decarbamylase immobilized enzyme 43 units / resin lg
- a hydantoinase immobilized enzyme was used as a resin in which two enzymes to be used as controls were separately immobilized.
- 21.8 g of the resin for immobilization was mixed with 60 ml of the crude enzyme solution and immobilized by the method shown in Example 2 (117 units, Z resin lg, ⁇ 1 unit / g (pH 7.5)).
- Example 5 Of the immobilized enzymes obtained in Example 5, 5 g of the complex immobilized enzyme and 5.6 g of the hydantoinase immobilized enzyme and 5.2 g of the dexamerubamylase immobilized enzyme as separately immobilized enzymes were mixed. Using the same enzyme (having the same decarbamylase activity (pH 7.5) and hydantoinase activity (PH 8.7) twice as high as the complex immobilized enzyme) in the method of Example 3 Reactions were performed with a concentration of substrate.
- the reaction of the complex immobilized enzyme shows almost the same reactivity despite the 1H2 hydantoinase activity, and the complex immobilized enzyme can perform the reaction more efficiently.
- expensive immobilization resin can be significantly reduced.
- Example 5 Using 5 g of each of the composite immobilized enzymes obtained in Example 5, the effect of pH during the reaction was examined. Reaction was carried out at 3 levels of pH 7.0, 7.25 and 7.5 by the method shown in Example 3 with a 3% concentration of the substrate. The reaction times required to convert 99% of the substrates were determined to be 5.5 hours, 5.4 hours, and 6.7 hours, respectively. 5 hours, pH 7.0 and 7.25 were found to be more favorable for the reaction.
- a composite immobilized enzyme preparation in which hydantoinase and decarbamylase are simultaneously immobilized on the same resin is used.
- a one-step reaction can be performed with a much simpler operation than a two-step reaction, and with higher reaction efficiency than a mixture of two kinds of immobilized enzymes in which these enzymes are immobilized on separate resins. It became possible.
- FIG. 1 shows the results of 5_ (p-hydroxyphenyl) hydantoin using the complex immobilized enzyme preparation and the mixture of immobilized enzymes obtained by immobilizing hydantoinase and decarbamylase in different resins in Example 3.
- FIG. 4 is a graph showing the generation of D—p-hydroxyphenylglycine corresponding to the time course.
- FIG. 2 is a graph showing the stability of the enzyme during the repeated reaction of the composite immobilized enzyme preparation in Example 4.
- FIG. 3 is a graph showing the results of a comparison of the enzyme activities of the composite immobilized enzyme preparation and a mixture of separate immobilized enzyme preparations (hydantoinase activity twice as high) in Example 6.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69531725T DE69531725T2 (de) | 1994-06-24 | 1995-06-23 | Verfahren zur herstellung von d-aminosäure durch eine zusammengesetzte immobilisierte enzymenverbindung |
EP95922746A EP0725142B1 (en) | 1994-06-24 | 1995-06-23 | Process for producing d-amino acid by using composite immobilized enzyme preparation |
US08/596,144 US5962279A (en) | 1994-06-24 | 1995-06-23 | Process for producing D-amino acids with composite immobilized enzyme preparation |
JP50301096A JP3996183B2 (ja) | 1994-06-24 | 1995-06-23 | 複合固定化酵素調製物を用いたd−アミノ酸の製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6/142977 | 1994-06-24 | ||
JP14297794 | 1994-06-24 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/596,144 Continuation US5962279A (en) | 1994-06-24 | 1995-06-23 | Process for producing D-amino acids with composite immobilized enzyme preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996000296A1 true WO1996000296A1 (fr) | 1996-01-04 |
Family
ID=15328063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1995/001257 WO1996000296A1 (fr) | 1994-06-24 | 1995-06-23 | Procede de production de d-amino acide au moyen d'une preparation a base d'une enzyme composite immobilisee |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0725142B1 (ja) |
JP (1) | JP3996183B2 (ja) |
KR (1) | KR100396536B1 (ja) |
CN (1) | CN1088473C (ja) |
DE (1) | DE69531725T2 (ja) |
ES (1) | ES2206512T3 (ja) |
WO (1) | WO1996000296A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0801131A1 (en) * | 1994-12-28 | 1997-10-15 | Kanegafuchi Chemical Industry Co., Ltd. | PROCESS FOR PRODUCING D-N-CARBAMOYL-$g(a)-AMINO ACID |
US5849488A (en) * | 1996-02-27 | 1998-12-15 | Oulutech Ltd. | DNA-sequence-based diagnosis of mastitis from a milk sample |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1276163B1 (it) * | 1995-11-23 | 1997-10-27 | Eniricerche Spa | Procedimento migliorato per la preparazione di d-alfa-amminoacidi |
CA2486350A1 (en) * | 2002-06-05 | 2003-12-24 | Kaneka Corporation | Process for producing optically active .alpha.-methylcysteine derivative |
US20060172393A1 (en) * | 2003-01-10 | 2006-08-03 | Kaneka Corporation | Process for producing optically active alpha -methylcysteine derivative |
CN1908159B (zh) * | 2005-02-07 | 2011-04-20 | 中国科学院上海生命科学研究院 | D-氨基酸生产菌株及其构建方法 |
CN100447240C (zh) * | 2006-01-06 | 2008-12-31 | 中国科学院上海生命科学研究院 | D-氨甲酰水解酶的突变体及其应用 |
CN105368913B (zh) * | 2015-12-22 | 2019-11-08 | 滨海瀚鸿生化有限公司 | 用于工业化生产手性非天然氨基酸的双酶制备法 |
CN111534506B (zh) * | 2020-05-13 | 2023-08-25 | 福州三合元生物科技有限公司 | 一种离子液体再生纤维素固定化酶的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02119796A (ja) * | 1988-10-28 | 1990-05-07 | Bio-Le Kk | L−ホモフエニルアラニンの製造法 |
JPH02276586A (ja) * | 1989-04-19 | 1990-11-13 | Bio-Le Kk | D‐ホモフエニルアラニンの製造法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4211840A (en) * | 1977-06-08 | 1980-07-08 | Ajinomoto Company, Incorporated | Method for producing D-α-amino acid |
ES2058121T3 (es) * | 1986-09-17 | 1994-11-01 | Beecham Group Plc | Preparacion enzimatica inmovilizada y su uso. |
US5565344A (en) * | 1990-12-07 | 1996-10-15 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for production of D-α-amino acids |
ES2042409B1 (es) * | 1992-04-10 | 1994-06-01 | Control & Gestion Instr | Procedimiento para la preparacion de d-aminoacidos o derivados de d-aminoacidos. |
JP3510625B2 (ja) * | 1992-06-30 | 2004-03-29 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | D−n−カルバモイル−アミノ酸アミドヒドロラーゼおよびヒダントイナーゼ |
-
1995
- 1995-06-23 DE DE69531725T patent/DE69531725T2/de not_active Expired - Fee Related
- 1995-06-23 JP JP50301096A patent/JP3996183B2/ja not_active Expired - Fee Related
- 1995-06-23 CN CN95190569A patent/CN1088473C/zh not_active Expired - Fee Related
- 1995-06-23 EP EP95922746A patent/EP0725142B1/en not_active Expired - Lifetime
- 1995-06-23 WO PCT/JP1995/001257 patent/WO1996000296A1/ja active IP Right Grant
- 1995-06-23 ES ES95922746T patent/ES2206512T3/es not_active Expired - Lifetime
- 1995-06-23 KR KR1019960700910A patent/KR100396536B1/ko not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02119796A (ja) * | 1988-10-28 | 1990-05-07 | Bio-Le Kk | L−ホモフエニルアラニンの製造法 |
JPH02276586A (ja) * | 1989-04-19 | 1990-11-13 | Bio-Le Kk | D‐ホモフエニルアラニンの製造法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP0725142A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0801131A1 (en) * | 1994-12-28 | 1997-10-15 | Kanegafuchi Chemical Industry Co., Ltd. | PROCESS FOR PRODUCING D-N-CARBAMOYL-$g(a)-AMINO ACID |
EP0801131A4 (en) * | 1994-12-28 | 2000-03-22 | Kanegafuchi Chemical Ind | METHOD FOR PRODUCING A D-N-CARBAMOYL ALPHA AMINO ACID |
US5849488A (en) * | 1996-02-27 | 1998-12-15 | Oulutech Ltd. | DNA-sequence-based diagnosis of mastitis from a milk sample |
Also Published As
Publication number | Publication date |
---|---|
CN1088473C (zh) | 2002-07-31 |
KR100396536B1 (ko) | 2003-11-20 |
DE69531725D1 (de) | 2003-10-16 |
DE69531725T2 (de) | 2004-07-08 |
EP0725142A4 (en) | 2000-06-14 |
KR960704058A (ko) | 1996-08-31 |
ES2206512T3 (es) | 2004-05-16 |
EP0725142B1 (en) | 2003-09-10 |
EP0725142A1 (en) | 1996-08-07 |
JP3996183B2 (ja) | 2007-10-24 |
CN1129957A (zh) | 1996-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101194020A (zh) | L-氨基酸的制造方法 | |
US4745061A (en) | Novel d-aminoacid transaminase and its use | |
WO1986007386A1 (en) | Process for preparing optically active, organic compounds | |
JPH0559709B2 (ja) | ||
WO1996000296A1 (fr) | Procede de production de d-amino acide au moyen d'une preparation a base d'une enzyme composite immobilisee | |
EP0330695B1 (en) | Process for preparation of organic chemicals | |
JP3409353B2 (ja) | アミド化合物の製造方法および使用される微生物 | |
US5834259A (en) | Process and composition for preparing D-aspartic acid | |
EP1616945A1 (en) | Process for producing D-N-carbamoyl-alpha-amino acids | |
JPH10507631A (ja) | 4−メチルチオブチロニトリルの酵素による加水分解 | |
US5962279A (en) | Process for producing D-amino acids with composite immobilized enzyme preparation | |
US6902915B2 (en) | Heat-stable D-aminoacylase | |
JP2902112B2 (ja) | D―α―アミノ酸の製造法 | |
JP5096911B2 (ja) | 5−置換ヒダントインラセマーゼ、これをコードするdna、組換えdna、形質転換された細胞、および、光学活性n−カルバミルアミノ酸または光学活性アミノ酸の製造方法 | |
US5420023A (en) | Process for producing L-phenylalanine | |
EP0352846B1 (en) | Process for the preparation of biocatalysts with previously absent stereoselective enzyme activity | |
EP0315786A1 (en) | Process for the preparation of a d-alfa-amino acid from the corresponding alfa-keto acid | |
JP3392865B2 (ja) | 固定化酵素調製物およびD―α―アミノ酸の製造法 | |
US20050112729A1 (en) | Recombinant DNA having hydantoinase gene and carbamylase gene and process for producing amino acid | |
JP4081124B2 (ja) | D−N−カルバモイル−α−アミノ酸の製造法 | |
JPH0630572B2 (ja) | L−フエニルアラニン脱水素酵素 | |
JPS6248395A (ja) | L−トリプトフアンの製造法 | |
JPS60176594A (ja) | L−トリプトフアンの製造方法 | |
JP2000270856A (ja) | 新規なアミノアルコール脱水素酵素、その製造方法および用途 | |
JPH06197776A (ja) | L−リンゴ酸またはその塩の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 95190569.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN JP KR SG US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995922746 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019960700910 Country of ref document: KR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1995922746 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08596144 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 1995922746 Country of ref document: EP |